Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
ePlus inc is a software-application business based in the US. ePlus shares (PLUS) are listed on the NASDAQ and all prices are listed in US Dollars. ePlus employs 1,560 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$94.57|
|52-week range||$66.91 - $107.64|
|50-day moving average||$88.71|
|200-day moving average||$94.37|
|Wall St. target price||$102.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$5.54|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-07-22)||N/A|
|1 month (2021-07-02)||8.96%|
|3 months (2021-04-30)||-5.77%|
|6 months (2021-01-29)||N/A|
|1 year (2020-07-29)||N/A|
|2 years (2019-07-29)||N/A|
|3 years (2018-07-29)||N/A|
|5 years (2016-07-29)||N/A|
Valuing ePlus stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of ePlus's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
ePlus's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 17x. In other words, ePlus shares trade at around 17x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
ePlus's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.86. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into ePlus's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
ePlus's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $127.6 million.
The EBITDA is a measure of a ePlus's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$1.6 billion|
|Operating margin TTM||6.86%|
|Gross profit TTM||$376.9 million|
|Return on assets TTM||6.78%|
|Return on equity TTM||14.19%|
|Market capitalisation||$1.2 billion|
TTM: trailing 12 months
There are currently 137,508 ePlus shares held short by investors – that's known as ePlus's "short interest". This figure is 6.8% up from 128,738 last month.
There are a few different ways that this level of interest in shorting ePlus shares can be evaluated.
ePlus's "short interest ratio" (SIR) is the quantity of ePlus shares currently shorted divided by the average quantity of ePlus shares traded daily (recently around 103389.47368421). ePlus's SIR currently stands at 1.33. In other words for every 100,000 ePlus shares traded daily on the market, roughly 1330 shares are currently held short.
However ePlus's short interest can also be evaluated against the total number of ePlus shares, or, against the total number of tradable ePlus shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case ePlus's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 ePlus shares in existence, roughly 10 shares are currently held short) or 0.0104% of the tradable shares (for every 100,000 tradable ePlus shares, roughly 10 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against ePlus.
Find out more about how you can short ePlus stock.
We're not expecting ePlus to pay a dividend over the next 12 months.
ePlus's shares were split on a 2:1 basis on 2 April 2017. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your ePlus shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for ePlus shares which in turn could have impacted ePlus's share price.
Over the last 12 months, ePlus's shares have ranged in value from as little as $66.91 up to $107.64. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ePlus's is 1.302. This would suggest that ePlus's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
ePlus inc. , together with its subsidiaries, provides information technology (IT) solutions that enable organizations to optimize their IT environment and supply chain processes in the United States and internationally. It operates in two segments, Technology and Financing. The Technology segment offers hardware, perpetual and subscription software, maintenance, software assurance, and internally provided and outsourced services; and professional and managed services, including ePlus managed, professional, security, ePlus cloud consulting, staff augmentation, server and desktop support, and project management services. The Financing segment specializes in financing arrangements, such as sales-type and operating leases; loans and consumption-based financing arrangements; and underwriting, management, and disposal of IT equipment and assets. Its financing operations comprise sales, pricing, credit, contracts, accounting, risk management, and asset management. This segment primarily finances IT, communication-related, and medical equipment; and industrial machinery and equipment, office furniture and general office equipment, transportation equipment, and other general business equipment directly, as well as through vendors.
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
Everything we know about the RenovoRx IPO, plus information on how to buy in.
Everything we know about the Draganfly IPO, plus information on how to buy in.
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
Everything we know about the Marpai IPO, plus information on how to buy in.
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.